The Effect of Everolimus and Low-Dose Cyclophosphamide on Immune Cell Subsets in Patients With Metastatic Renal Cell Carcinoma: Results From a Phase I Clinical Trial
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-018-2288-8
Full Text
Open PDFAbstract
Available in full text
Date
January 17, 2019
Authors
Publisher
Springer Science and Business Media LLC